Revolutionizing cancer treatment: the rise of personalized immunotherapies
Discover Oncology · 18.12.2024 · 15 (1)
DOI: 10.1007/s12672-024-01638-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 18.12.2024. Verfasst von Amna Fayyaz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Interest in biological therapy for cancer has surged due to its precise targeting of cancer cells and minimized impact on surrounding healthy tissues. This review discusses various biological cancer therapies, highlighting advanced alternatives over conventional chemotherapy alone. It explores DNA and RNA-based vaccines, T-cell modifications, adoptive cell transfer, CAR T cell therapy, angiogenesis inhibitors, and the combination of immunotherapy with chemotherapy, offering a holistic view of the potential in cancer treatment. Additionally, it discusses the role of nanotechnology in increasing the efficacy of cancer-targeting drugs, as well as cytokine and immunoconjugate therapies for bolstering immune system effectiveness against neoplastic cells. The potential of gene potential for precise targeting of cancer-linked genes and the application of oncolytic viruses against virus-associated cancers are also discussed. The review identifies significant advancements in the targeted treatment of cancer by biological methods. It acknowledges the challenges, including drug resistance and the need for high specificity in certain therapies, while also highlighting the effectiveness of cancer vaccines, modified T-cells, and oncolytic viruses. Biological therapies are a promising frontier in cancer treatment, offering the potential for more personalized and effective therapeutic strategies. Despite existing challenges, ongoing research and clinical trials are fundamental for overcoming current limitations and enhancing the efficacy of biological therapies in cancer care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.
- School of Medical Laboratory Technology, Faculty of Allied Health Sciences, Minhaj University Lahore (MUL), Lahore, 54000, Pakistan.
- Department of Pharmacy, Punjab University College of Pharmacy University of Punjab Lahore, Lahore, 54000, Pakistan.
- Cancer Clinical Research Unit, Trials360, Lahore, 54000, Pakistan. khushi-khan2011@hotmail.com.
- Department for Metabolic Diseases, University Hospital Center Zagreb, Zagreb, Croatia.
- Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
Zitieren
APA
Fayyaz, A., Haqqi, A., Khan, R., Irfan, M., Khan, K., Reiner, Ž., Sharifi-Rad, J., & Calina, D. (2024). Revolutionizing cancer treatment: the rise of personalized immunotherapies. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01638-1
Vancouver
Fayyaz A, Haqqi A, Khan R, Irfan M, Khan K, Reiner Ž, et al. Revolutionizing cancer treatment: the rise of personalized immunotherapies. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01638-1
BibTeX
@article{Fayyaz2024,
author = {Fayyaz, Amna and Haqqi, Aleena and Khan, Rashid and Irfan, Muhammad and Khan, Khushbukhat and Reiner, Željko and Sharifi-Rad, Javad and Calina, Daniela},
title = {Revolutionizing cancer treatment: the rise of personalized immunotherapies},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-01638-1}
}
EUVIMED